4//SEC Filing
BELLICUM PHARMACEUTICALS, INC 4
Accession 0001358403-17-000132
CIK 0001358403operating
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:14 PM ET
Size
5.5 KB
Accession
0001358403-17-000132
Insider Transaction Report
Form 4
Spencer David M.
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2017-07-03+26,250→ 26,250 totalExercise: $11.70Exp: 2027-07-02→ Common Stock (26,250 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on January 1, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeoperating
Related Parties
1- filerCIK 0001358403
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:14 PM ET
- Size
- 5.5 KB